UCL Institute of Cardiovascular Science


Subcutaneous implantable cardioverter defibrillator (S-ICD) devices maintain cardioversion efficacy.

4 May 2021

Professor Pier Lambiase

Professor Pier Lambiase, Institute of Cardiovascular Science, University College London and Barts Heart Centre (London, UK), presented five-year findings from the EFFORTLESS study at the recent European Heart Rhythm Association congress, showing that  Subcutaneous implantable cardioverter defibrillator (S-ICD) devices have demonstrated a cardioversion efficacy rate of 98%. More information on the study and Professor Lambiase’s presentation can be found here.